Accepted Manuscript Targeted Nrf2 activation therapy with RTA 408 enhances regenerative capacity of diabetic wounds Piul S. Rabbani, Trevor Ellison, Bukhtawar Waqas, Darren Sultan, Salma Abdou, Joshua A David, Joshua M. Cohen, Alejandro Gomez-Viso, Gretl Lam, Camille Kim, Jennifer Thomson, Daniel J. Ceradini PII: S0168-8227(17)31556-5 DOI: https://doi.org/10.1016/j.diabres.2018.02.021 Reference: DIAB 7234 To appear in: Diabetes Research and Clinical Practice Received Date: 27 September 2017 Revised Date: 2 January 2018 Accepted Date: 13 February 2018 Please cite this article as: P.S. Rabbani, T. Ellison, B. Waqas, D. Sultan, S. Abdou, J.A. David, J.M. Cohen, A. Gomez-Viso, G. Lam, C. Kim, J. Thomson, D.J. Ceradini, Targeted Nrf2 activation therapy with RTA 408 enhances regenerative capacity of diabetic wounds, Diabetes Research and Clinical Practice (2018), doi: https://doi.org/ 10.1016/j.diabres.2018.02.021 This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.